Please login to the form below

sumatriptan

This page shows the latest sumatriptan news and features for those working in and with pharma, biotech and healthcare.

Lilly to buy migraine drug developer CoLucid for $960m

Current triptan migraine therapies such as sumatriptan target different 5-HT receptor subtypes, notably 1B and 1D receptors, and stimulating these leads to constriction of blood vessels in the brain as

Latest news

Teva suspends migraine patch on burn reports

Zecuity delivers sumatriptan across the skin by a process known as iontophoresis - in which a mild electric current is applied across the skin and helps to usher active pharmaceutical compounds into ... The AERs are puzzling because iontophoresis has
Teva rolls out first migraine patch in US

The new Zecuity product is a disposable patch system worn for four-hours - on the upper arm or thigh - that delivers the widely-used migraine drug sumatriptan through the skin. ... Sumatriptan is a serotonin 5-HT1 agonist that has been used for years in
Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal

In the last few months it has also bought NuPathe for $105m - getting hold of migraine patch Zecuity (sumatriptan) - and in June offered $600m for generic player DAVA Pharmaceuticals.
GSK plans to sell off older products

Imitrex (sumatriptan) for migraine, the antidepressant Paxil/Seroxat (paroxetine) and gastrointestinal therapy Zantac (ranitidine) have all been named in dispatches as former blockbuster brands that are now in GSK's 'established
Second darapladib failure disappoints GSK

Sells Treximet to Pernix. Meanwhile, GSK has sold off another brand as it reconfigures its product portfolio, this time handing over US rights to migraine therapy Treximet (sumatriptan/naproxen) to US

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest Intelligence

Case study: Migraine management

Challenge. Eight years ago, Imigran Recovery (sumatriptan) made the switch from a ‘ POM’ medication to a ‘ P’ licence medicine in a bid to make it more accessible to people who experience ... 80 per cent of coverage mentioned efficacy of
Case study: Migraine management

Challenge. Eight years ago, Imigran Recovery (sumatriptan) made the switch from a ‘ POM’ medication to a ‘ P’ licence medicine in a bid to make it more accessible to people who experience ... 80 per cent of coverage mentioned efficacy of
Deal Watch table for May 2014

Asset / product acquisition. 3. Marketed sumatriptan/naproxen combination. 2013 sales $79m.
Deal Watch table for January 2014

148. NuPathe/ Teva. Company acquisition. Includes key product Zecuity [sumatriptan] for migraine.
Deal Watch table for July 2013

121. ‡ Optinose / Avanir Pharmaceuticals. Licence. Breath Powered intranasal sumatriptan for migraine (p3).

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Director or Senior Account Director: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Senior Medical Writer: Salary is DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Healthcare PR Senior Account Manager: Salary TBC

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Account Manager: Negotiable

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Senior Writer, Healthcare Advertising, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Account Manager- 4 days per week or full-time: Salary TBC

Associate Scientific Director: Salary TBC

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...